Euromedis Groupe SA (ALEMG) - Total Assets
Based on the latest financial reports, Euromedis Groupe SA (ALEMG) holds total assets worth €39.78 Million EUR (≈ $46.50 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Euromedis Groupe SA for net asset value and shareholders' equity analysis.
Euromedis Groupe SA - Total Assets Trend (2009–2024)
This chart illustrates how Euromedis Groupe SA's total assets have evolved over time, based on quarterly financial data.
Euromedis Groupe SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Euromedis Groupe SA's total assets of €39.78 Million consist of 97.1% current assets and 2.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 39.1% |
| Accounts Receivable | €8.64 Million | 22.3% |
| Inventory | €11.94 Million | 30.8% |
| Property, Plant & Equipment | €812.64K | 2.1% |
| Intangible Assets | €189.81K | 0.5% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2009–2024)
This chart illustrates how Euromedis Groupe SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Euromedis Groupe SA (ALEMG) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Euromedis Groupe SA's current assets represent 97.1% of total assets in 2024, an increase from 65.1% in 2009.
- Cash Position: Cash and equivalents constituted 39.1% of total assets in 2024, up from 3.0% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 23.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 30.8% of total assets.
Euromedis Groupe SA Competitors by Total Assets
Key competitors of Euromedis Groupe SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Euromedis Groupe SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.07 | 3.47 | 1.40 |
| Quick Ratio | 2.25 | 2.57 | 1.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €26.01 Million | €27.43 Million | €27.26 Million |
Euromedis Groupe SA - Advanced Valuation Insights
This section examines the relationship between Euromedis Groupe SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | -16.1% |
| Total Assets | €38.79 Million |
| Market Capitalization | $14.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Euromedis Groupe SA's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Euromedis Groupe SA's assets decreased by 16.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Euromedis Groupe SA (2009–2024)
The table below shows the annual total assets of Euromedis Groupe SA from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €38.79 Million ≈ $45.35 Million |
-16.15% |
| 2023-12-31 | €46.26 Million ≈ $54.08 Million |
-22.73% |
| 2022-12-31 | €59.87 Million ≈ $69.99 Million |
-17.68% |
| 2021-12-31 | €72.72 Million ≈ $85.02 Million |
-21.48% |
| 2020-12-31 | €92.61 Million ≈ $108.28 Million |
+53.95% |
| 2019-12-31 | €60.16 Million ≈ $70.33 Million |
+19.47% |
| 2018-12-31 | €50.36 Million ≈ $58.87 Million |
-12.03% |
| 2017-12-31 | €57.24 Million ≈ $66.92 Million |
+0.86% |
| 2016-12-31 | €56.75 Million ≈ $66.35 Million |
+0.36% |
| 2015-12-31 | €56.55 Million ≈ $66.11 Million |
+1.99% |
| 2014-12-31 | €55.44 Million ≈ $64.82 Million |
+0.97% |
| 2013-12-31 | €54.91 Million ≈ $64.20 Million |
-0.44% |
| 2012-12-31 | €55.15 Million ≈ $64.48 Million |
-1.80% |
| 2011-12-31 | €56.16 Million ≈ $65.66 Million |
+1.17% |
| 2010-12-31 | €55.51 Million ≈ $64.90 Million |
+3.38% |
| 2009-12-31 | €53.69 Million ≈ $62.77 Million |
-- |
About Euromedis Groupe SA
Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more